Health encyclopaedia - Alphabetical Topic List

| A | | B | | C | | D | | E | | F | | G | | H | | I | | J | | K | | L | | M |
| N | | O | | P | | Q | | R | | S | | T | | U | | V | | W | | X | | Y |

References of Prostate disease

Health Technology Assessment 1997; Vol. 1: No. 2 Diagnosis, management and screening of early localised prostate cancer. Selley S et al. http://www.ncchta.org/execsumm/summ103.htm

Maximal androgen blockade for advanced prostate cancer (Cochrane Review) Schmitt B, Bennett C, Seidenfeld. From The Cochrane Library, Issue 1, 2002. Prepared and published by Update Software Ltd. All rights reserved. http://www.update-software.com/abstracts/ab001526.htm

Anonymous (1995) Benign Prostatic Hyperplasia: Treatment for Lower Urinary Tract Symptoms in Older Men. Effective Health Care Bulletin 2, 2. http://www.york.ac.uk/inst/crd/ehc22.htm

Anonymous (1998) Benign prostatic hyperplasia. Medicines Resource 49, 191-194.

Anonymous (1995) Finasteride and benign prostatic hyperplasia. Drug & Therapeutics Bulletin 33, 19-21.

Anonymous (1998) Management of benign prostatic hyperplasia. MeReC Bulletin 9, 1-4.

Cockett, A.T.K. and et.al., (Eds.) Jun 27, 1993. The 2nd international conference on benign prostatic hyperplasia 27-30 June, 1993. 553 p. Scientific Comm. Int. Ltd. (1993)

Cockett, A.T.K. and et.al., (Eds.) Jun 27, 1993. The 2nd international conference on benign prostatic hyperplasia 27-30 June, 1993. 427 p. Scientific Comm. Int. Ltd. (1993)

Cockett, A.T.K. and et.al., (Eds.) Jun 27, 1993. The 2nd international conference on benign prostatic hyperplasia 27-30 June, 1993. 276 p. Scientific Comm. Int. Ltd. (1993)

Andersen, J.T., Ekman, P., Wolf, H., Beisland, H.O., Johansson, J.E., Kontturi, M., Lehtonen, T. and Tveter, K. (1995) Can finasteride reverse the progress of benign prostatic hyperplasia? A two-year placebo-controlled study. The Scandinavian BPH Study Group. Urology 46, 631-637.

Bandolier (1998) Benign prostatic hyperplasia outcomes. Bandolier 5, 4

Bandolier (1997) BPH and finasteride - more results. Bandolier 4, 5

Boyle, P., Gould, A.L. and Roehrborn, C.G. (1996) Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: meta-analysis of randomized clinical trials [see comments]. Urology 48, 398-405.

Chair: McConnell, J.D. (1994) Benign Prostatic Hyperplasia: diagnosis and treatment. Clinical practice guideline. AHCPR.

Coffey, D.S. (1998) Controversies in the management of lower urinary tract symptoms: an overview. [Review] [36 refs]. British Journal of Urology 81 Suppl 1, 1-5.

DoH (2000) Referral Guidelines for Suspected Cancer. Chapter 6, Urological Cancers.

Eri, L.M. and Tveter, K.J. (1995) alpha-blockade in the treatment of symptomatic benign prostatic hyperplasia [see comments]. [Review] [131 refs]. Journal of Urology 154, 923-934.

Lepor, H., Williford, W.O., Barry, M.J., Brawer, M.K., Dixon, C.M., Gormley, G., Haakenson, C., Machi, M., Narayan, P. and Padley, R.J. (1996) The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group [see comments]. New England Journal of Medicine 335, 533-539.

Lepor, H. (1998) The pathophysiology of lower urinary tract symptoms in the ageing male population. [Review] [24 refs]. British Journal of Urology 81 Suppl 1, 29-33.

McConnell, J.D., Bruskewitz, R., Walsh, P., Andriole, G., Lieber, M., Holtgrewe, H.L., Albertsen, P., Roehrborn, C.G., Nickel, J.C., Wang, D.Z., Taylor, A.M. and Waldstreicher (1998) The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group [see comments]. New England Journal of Medicine 338, 557-563.

O'Leary, M.P. (1995) Epidemiology of benign prostatic hyperplasia. [Review] [14 refs]. British Journal of Urology 76 Suppl 1, 1-3.

Simpson, R.J. (1997) Benign prostatic hyperplasia [see comments]. [Review] [114 refs]. British Journal of General Practice 47, 235-240.

Suzuki, H. (1998) Treatment of benign prostatic hyperplasia and hypertension in elderly hypertensive patients. BRIT J UROL SUPPL 81, 51-55.

UK British Prostate Group ., Carne, S.J., Fitzpatrick, J.M., George, N.J., Gingell, J.C., Keen, J.W., Kirby, R.S., Kirk, D., O'Donoghue, E.P., Peeling, W.B. and Chisholm, G.D. (1995) Prostate disease: management options for the primary healthcare team. Report of a working party of the British Prostate Group. Postgraduate Medical Journal 71, 136-142.

Wasson, J.H., Reda, D.J., Bruskewitz, R.C., Elinson, J., Keller, A.M. and Henderson, W.G. (1995) A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate [see comments]. New England Journal of Medicine 332, 75-79.